Navigation Links
Leading Pharma Company Selects Clinilabs to Conduct a Phase 1 Study of an Investigational Type 2 Diabetes Medication
Date:9/30/2013

NEW YORK, Sept. 30, 2013 /PRNewswire-iReach/ -- Clinilabs, a contract research organization that provides early-stage and specialty clinical drug development services to industry, announced today that they have begun a Phase I clinical research study of an investigational medication for Type 2 Diabetes Mellitus.  The study is being conducted to assess the safety and tolerability of multiple daily doses of the investigational medication over periods of up to 28 days.  

Diabetes has become one of the most prevalent diseases in the United States, with approximately 2 million people diagnosed each year.  The Center for Disease Control and Prevention estimates that roughly 35% of the population over the age of 20 is pre-diabetic.  For those over the age of 65, this number increases to 50%.  Clinilabs understands the growing need for treatment options in this field and is dedicated to helping sufferers combat the disease.  In response to the study award, Lead Recruiter Carrie Sorkin states: "Patients understand that clinical trials are a great way to find alternative treatment options for diabetes.  At Clinilabs, we have seen this first-hand through the great success we have had in our recruitment efforts."

Clinilabs is currently enrolling male and female volunteers, between the ages of 18 and 70, who have been diagnosed with Type 2 Diabetes Mellitus.  Any female patients interested in volunteering for this study must not be of childbearing potential. Patients must be on a stable treatment regimen for at least 4 weeks prior to screening and must have a body weight of above 45.0 kg.

Individuals in the Central New Jersey area who would like to participate can contact our dedicated call center at 212-994-4567 to prequalify.  Additional information may also be found by visiting www.cli
'/>"/>

SOURCE Clinilabs
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Leading evolutionary scientist to discuss how genome of bacteria has evolved
2. Worlds leading coral experts to gather in Australia
3. Putting plants online: 4 leading botanical gardens to create first online catalog of all plants
4. EMBO welcomes 55 leading life scientists as members
5. Leading statistician receives national citation award
6. Leading childhood asthma group supports federal asthma action plan to reduce disparities
7. BiOptix Participates in Leading Life Sciences Event BioWest 2012
8. Team including UC Riverside entomologist honored for research leading to healthier potato chips
9. Aware Enables Automated Delivery of Radiation Dose Information Through Integration With Leading Radiology Reporting System
10. Discovery of pathway leading to depression reveals new drug targets
11. Leading RSV researcher publishes work at Le Bonheur Childrens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... changing climate threaten some of the world,s most ... establish seed collections to save the seeds in ... some genetic diversity., For decades, these seed collections ... a one-size-fits-all approach for how many seeds to ... regardless of species, pollination mode, growth habitat and ...
(Date:7/30/2014)... from Bjorn Brembs, professor of neurogenetics at the Institute ... figure allowing readers and reviewers to run the underlying ... important leap forward for scientific publishing, by demonstrating a ... scholarly output. , Figure 3 in fact doesn,t really ... to F1000Research , and the figure is generated ...
(Date:7/30/2014)... injury (SCI), traumatic brain injury (TBI) and peripheral nerve ... learned over the past 30 years regarding both the ... growth, but this large body of information has not ... his team from University of Miami in USA proposed ... consensus is emerging that one contributing factor is a ...
Breaking Biology News(10 mins):Saving seeds the right way can save the world's plants 2F1000Research brings static research figures to life 2
... Hagfish is a strange animal: it feeds by gnawing its way ... 3 days. Scientists at the University of British Columbia (Canada) believe ... inside the carcass to become acidic from the build up of ... is able to cope with environmental conditions of up to 7% ...
... to a low-weight preemie at 24 weeks, exhibited the first-found ... and the amniotic fluid of a woman in preterm labor. ... cannot be cultured and grown in the lab, researchers from ... Department of Obstetrics and Gynecology at MetroHealth Medical Center in ...
... Dr. Peter Sarnow and a team of Stanford University scientists ... named miR-122, in order to replicate in cultured liver cells. ... amount of hepatitis C virus RNA was reduced by approximately ... potential to develop new antiviral agents against hepatitis C, the ...
Cached Biology News:Prenatal nicotine exposure reduces breathing response of newborns... 2Prenatal nicotine exposure reduces breathing response of newborns... 3
(Date:7/30/2014)... Hartford, CT (PRWEB) July 30, 2014 ... economic development organization based in East Hartford, Conn., was ... on Phase II of a project that will determine ... facility in rural north-central Connecticut. USDA Rural Development provided ... (RBEG) program for the second phase of the feasibility ...
(Date:7/30/2014)... Arlington, MA (PRWEB) July 30, 2014 ... products, announces completion of its first round of seed ... round will enable preliminary efforts to develop a novel ... the support of our investors and their commitment to ... CEO of LayerBio. "Ophthalmology is one of many areas ...
(Date:7/29/2014)... The advanced optical methods and applications for ... a revolution in the neurosciences were the inspiration behind ... SPIE, the international society for optics and photonics ... of the BRAIN Initiative in the United States, and ... vision for and provide examples of the impact that ...
(Date:7/29/2014)... foam of atom-thick sheets can be made to any ... Rice University. , In microscopic images, the foam ... and walls that reinforce each other. The structure consists ... of graphene oxide that self-assemble with the assistance of ... the foam could find use in structural components, as ...
Breaking Biology Technology:USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4Tough foam from tiny sheets 2
... 2012  Argos Therapeutics Inc., today announced that it ... AGS-003-006, a Phase 2 study of its Arcelis™ ... with advanced renal cell carcinoma (RCC). The results ... T cell responses and overall survival. AGS-003 in ...
... DIEGO, Jan. 31, 2012  bioTheranostics, Inc., a bioMerieux ... drive personalized treatment, has introduced a new product ... resistance and pathway interrogation called PRECIS Precision Medicine ... cancer management, partners accurate diagnosis of primary tumor ...
... science world, with the potential to create foldaway mobile phones, ... new finding at the University of Manchester gives graphene,s potential ... for distilling alcohol. In a report published in ... shows that graphene-based membranes are impermeable to all gases and ...
Cached Biology Technology:Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC) 2Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC) 3bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation 2bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation 3Supermaterial goes superpermeable 2
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Preadipocyte factor-1 [Pref-1, DLK-1], C-terminal...
IC50: 35 ng/ml · Limit of detection: 8 ng/ml...
, Glycerol 30%...
Biology Products: